Acyclovir: Mechanism of Antiviral Action and Potentiation by Ribonucleotide Reductase Inhibitors
- 1 January 1991
- book chapter
- Published by Elsevier
- Vol. 22, 1-27
- https://doi.org/10.1016/s1054-3589(08)60031-9
Abstract
No abstract availableKeywords
This publication has 77 references indexed in Scilit:
- Synergistic topical therapy by acyclovir and A1110U for herpes simplex virus induced zosteriform rash in miceAntiviral Research, 1991
- Progressive Disease Due to Ganciclovir-Resistant Cytomegalovirus in Immunocompromised PatientsNew England Journal of Medicine, 1989
- Inhibition of ribonucleotide reductases encoded by herpes simplex virusesPharmacology & Therapeutics, 1985
- Elementary steps in the DNA polymerase I reaction pathwayBiochemistry, 1983
- Specificity of the catalytic interaction of human DNA polymerase .beta. with nucleic acid substratesBiochemistry, 1982
- Resistance to Antiviral Drugs of Herpes Simplex Virus Isolated from a Patient Treated with AcyclovirNew England Journal of Medicine, 1982
- Ordered sequential mechanism of substrate recognition and binding by KB cell DNA polymerase .alpha.Biochemistry, 1981
- Viral-associated and induced enzymesPharmacology & Therapeutics, 1979
- Ribonucleotide Reductase from Herpes Simplex Virus (Types 1 and 2) Infected and Uninfected KB Cells: Properties of the Partially Purified EnzymesJournal of General Virology, 1977
- Acquisition of thymidine kinase activity by herpes simplex infected mouse fibroblast cellsBiochemical and Biophysical Research Communications, 1963